Mesoblastic nephroma
For patient information click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Synonyms and keywords: Congenital mesoblastic nephroma; Fetal renal hamartoma
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Mesoblastic nephroma is a type of kidney tumor. Mesoblastic nephroma is a rare disease that tends to affect children under 3 years of age, especially neonates.[1][2] The male to female ratio is approximately 2 to 1.[3] Mesoblastic nephroma may be classified according to pathology into three subtypes: classic, cellular, and mixed mesoblastic nephroma.[4] Mesoblastic nephroma may be caused by translocation t(12:15)(p13;q25) that generates the fusion of ETV6/NTRK3 gene.[5] On gross pathology, a solid nonencapsulated mass that often occurs near the renal hilum is the characteristic finding of mesoblastic nephroma. On microscopic histopathological analysis, spindle cell is the characteristic finding of classic mesoblastic nephroma; whereas, plump cells with vesicular nuclei is the characteristic finding of cellular mesoblastic nephroma.[6] Mesoblastic nephroma must be differentiated from rhabdoid tumor, clear cell sarcoma of the kidney, and Wilm’s tumor. Symptoms of mesoblastic nephroma include polyhydramnios, hematuria, and abdominal distension. Biopsy is helpful in the diagnosis of mesoblastic nephroma. The predominant therapy for mesoblastic nephroma is surgical resection. Adjunctive chemotherapy may be required for cellular mesoblastic nephroma.[4] Prognosis is generally excellent, and the 5-year survival rate of patients with mesoblastic nephroma is approximately 96%.[7]
Classification
Mesoblastic nephroma may be classified according to pathology into three subtypes: classic, cellular, and mixed mesoblastic nephroma.[4]
Pathophysiology
On gross pathology, a solid nonencapsulated mass that often occurs near the renal hilum is the characteristic finding of mesoblastic nephroma. On microscopic histopathological analysis, spindle cell is the characteristic finding of classic mesoblastic nephroma; whereas, plump cells with vesicular nuclei is the characteristic finding of cellular mesoblastic nephroma.[8]
Causes
Mesoblastic nephroma may be caused by translocation t(12:15)(p13;q25) that generates the fusion of ETV6/NTRK3 gene.[5]
Differential diagnosis
Mesoblastic nephroma must be differentiated from rhabdoid tumor, clear cell sarcoma of the kidney, and Wilm’s tumor.
Epidemiology and Demographics
Mesoblastic nephroma is a rare disease that tends to affect children under 3 years of age, especially neonates. [1][9] The male to female ratio is approximately 2 to 1.[3]
Risk Factors
There are no established risk factors for mesoblastic nephroma.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for mesoblastic nephroma.[10]
Complications and Prognosis
Complications of mesoblastic nephroma include stillbirth, shoulder dystocia at birth, hydrops fetalis, and respiratory distress syndrome. Prognosis is generally excellent, and the 5-year survival rate of patients with mesoblastic nephroma is approximately 96%.[7]
Staging
There is no established system for the staging of mesoblastic nephroma.
Diagnosis
Symptoms
Symptoms of mesoblastic nephroma include polyhydramnios, hematuria, and abdominal distension.
Physical Examination
Common physical examination findings of mesoblastic nephroma include pallor and an palpated abdominal mass.
Laboratory Findings
There are no laboratory findings associated with mesoblastic nephroma.
X Ray
Abdominal X-ray may be helpful in the diagnosis of mesoblastic nephroma.
CT Scan
CT scan may be helpful in the diagnosis of mesoblastic nephroma.
MRI
MRI may be helpful in the diagnosis of mesoblastic nephroma.
Ultrasound
Ultrasound may be helpful in the diagnosis of mesoblastic nephroma.
Other Imaging Findings
There are no other imaging findings associated with mesoblastic nephroma.
Other Diagnostic Studies
There are no other diagnostic study findings associated with mesoblastic nephroma.
Biopsy
Biopsy is helpful in the diagnosis of mesoblastic nephroma.
Treatment
Medical Therapy
The predominant therapy for mesoblastic nephroma is surgical resection. Adjunctive chemotherapy may be required for cellular mesoblastic nephroma.[4]
Surgery
Surgery is the mainstay of treatment for mesoblastic nephroma.
Primary Prevention
There is no established method for prevention of mesoblastic nephroma.
Secondary Prevention
There are no secondary preventive measures available for mesoblastic nephroma.
References
- ↑ 1.0 1.1 Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma
- ↑ Tavassoli, Fattaneh (2003). Pathology and genetics of tumours of the breast and female genital organs. Lyon: IAPS Press. ISBN 9283224124.
- ↑ 3.0 3.1 Furtwaengler R, Reinhard H, Leuschner I, Schenk JP, Goebel U, Claviez A; et al. (2006). “Mesoblastic nephroma–a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH)”. Cancer. 106 (10): 2275–83. doi:10.1002/cncr.21836. PMID 16596620.
- ↑ 4.0 4.1 4.2 4.3 Malkan AD, Loh A, Bahrami A, et al. (2015). “An approach to renal masses in pediatrics”. Pediatrics. 135 (1): 142–58. doi:10.1542/peds.2014-1011. PMID 25452658.
- ↑ 5.0 5.1 Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH (1998). “A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma”. Nature Genetics. 18 (2): 184–7. doi:10.1038/ng0298-184. PMID 9462753.
- ↑ Humphrey, Peter (2008). The Washington manual of surgical pathology. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0781765275.
- ↑ 7.0 7.1 van den Heuvel-Eibrink MM, Grundy P, Graf N, Pritchard-Jones K, Bergeron C, Patte C; et al. (2008). “Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups”. Pediatr Blood Cancer. 50 (6): 1130–4. doi:10.1002/pbc.21389. PMID 18095319.
- ↑ Humphrey, Peter (2008). The Washington manual of surgical pathology. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0781765275.
- ↑ Tavassoli, Fattaneh (2003). Pathology and genetics of tumours of the breast and female genital organs. Lyon: IAPS Press. ISBN 9283224124.
- ↑ Mesoblastic nephroma. U.S. Preventive Service Task Force (USPSTF) 2015. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=mesoblastic+nephroma Accessed on November, 3, 2015
Historical Perspective
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Mesoblastic nephroma may be classified according to pathology into three subtypes: classic, cellular, and mixed mesoblastic nephroma.
Classification
Mesoblastic nephroma may be classified according to pathology into three subtypes:[1]
- Classic mesoblastic nephroma (24%)
- Cellular mesoblastic nephroma (66%)
- Mixed mesoblastic nephroma (10%)
References
- ↑ Malkan AD, Loh A, Bahrami A, et al. (2015). “An approach to renal masses in pediatrics”. Pediatrics. 135 (1): 142–58. doi:10.1542/peds.2014-1011. PMID 25452658.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
On gross pathology, a solid nonencapsulated mass that often occurs near the renal hilum is the characteristic finding of mesoblastic nephroma. On microscopic histopathological analysis, spindle cell is the characteristic finding of classic mesoblastic nephroma; whereas, plump cells with vesicular nuclei is the characteristic finding of cellular mesoblastic nephroma.[1]
Genetics
- Translocation t(12:15)(p13;q25) that generates the fusion of ETV6/NTRK3 gene is involved in the pathogenesis of mesoblastic nephroma.[2]
Gross Pathology
Characteristic findings of mesoblastic nephroma include:[3]
- Solid nonencapsulated mass
- Often occurs near the renal hilum
- Tends to invade the surrounding structures and renal parenchyma
- Hemorrhage and necrosis are infrequent
Microscopic Pathology
Classic mesoblastic nephroma[4]
- Spindle cells in fascicles
- Infiltrative border
Cellular mesoblastic nephroma
- Plump cells with vesicular nuclei
- Well-defined border
- Mitotically active
Mixed mesoblastic nephroma
- Both classic pattern and cellular pattern areas are present
References
- ↑ Humphrey, Peter (2008). The Washington manual of surgical pathology. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0781765275.
- ↑ Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH (1998). “A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma”. Nature Genetics. 18 (2): 184–7. doi:10.1038/ng0298-184. PMID 9462753.
- ↑ Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma
- ↑ Humphrey, Peter (2008). The Washington manual of surgical pathology. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0781765275.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Mesoblastic nephroma may be caused by translocation t(12:15)(p13;q25) that generates the fusion of ETV6/NTRK3 gene.[1]
Causes
Mesoblastic nephroma may be caused by translocation t(12:15)(p13;q25) that generates the fusion of ETV6/NTRK3 gene.[1]
References
- ↑ 1.0 1.1 Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH (1998). “A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma”. Nature Genetics. 18 (2): 184–7. doi:10.1038/ng0298-184. PMID 9462753.
Differentiating Mesoblastic nephroma
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Mesoblastic nephroma must be differentiated from rhabdoid tumor, clear cell sarcoma of the kidney, and Wilm’s tumor.
Differential diagnosis
Mesoblastic nephroma must be differentiated from:[1][2][3][4][5][6][7][8][9][10][11]
- Rhabdoid tumor
- Clear cell sarcoma of the kidney
- Wilm’s tumor
- Adrenal hematoma
- Intrarenal neuroblastoma
| S.No. | Disease | Symptoms | Signs | Diagnosis | Comments | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Abdominal Pain | Hematuria | Headache | Abdominal mass | Abdominal tenderness | Ultrasonography | CT scan | Histology | |||
| 1. | Wilms tumor | + | + | – | + | + |
|
|
|
|
| 2. | Renal cell carcinoma | + | + | +/- | + | – |
|
Both CT and MRI may be used to detect neoplastic masses that may define renal cell carcinoma or metastasis of the primary cancer. CT scan and use of intravenous (IV) contrast is generally used for work-up and follow-up of patients with renal cell carcinoma. | The histological pattern of renal cell carcinoma depends whether it is papillary, chromophobe or collecting duct renal cell carcinoma. | |
| 3. | Rhabdoid kidney disease | + | + | – | + | – |
|
|
|
|
| 4. | Polycystic kidney disease | + | + | + (from hypertension) | + | – |
Ultrasound may be helpful in the diagnosis of polycystic kidney disease. Findings on an ultrasound diagnostic of polycystic kidney disease include:[16][17] |
Renal CT scan may be helpful in the diagnosis of polycystic kidney disease. Findings on CT scan diagnostic of ADPKD include:
|
||
| 5. | Pheochromocytoma | – | – | + (as a part of the hypertension paroxysm) | – | – |
|
The following findings may be observed on CT scan:[22]
|
|
|
| 6. | Burkitt lymphoma | +/- (in non-endemic or sporadic form of the disease) | – | – | – | – |
|
|
|
|
| 7. | Intussusception | + | – | – | +/- | + |
|
|
|
|
| 8. | Hydronephrosis | + | +/- | – | – | + (CVA tenderness in case of pyelonephritis) |
|
|
|
|
| 9. | Dysplastic kidney | N/A | N/A | N/A | N/A | N/A |
MCDK is usually diagnosed by ultrasound examination before birth.
|
|
||
| 10. | Pediatric Neuroblastoma | + | – | – | +/- | +/- |
|
|
|
|
| 11. | Pediatric Rhabdomyosarcoma | + | +/- | +/- | – | +/- | On CT scan, rhabdomyosarocma is characterized by:
|
|
||
| 12. | Mesoblastic nephroma | + | + | – | + | – |
|
|
Classic mesoblastic nephroma
Cellular mesoblastic nephroma
Mixed mesoblastic nephroma
|
Most common renal tumor that occurs in 1st month of life |
References
- ↑ Mesoblastic nephroma. Wikipedia 2015. https://en.wikipedia.org/wiki/Mesoblastic_nephroma
- ↑ Garnier S, Maillet O, Haouy S, Saguintaah M, Serre I, Galifer RB; et al. (2012). “Prenatal intrarenal neuroblastoma mimicking a mesoblastic nephroma: a case report”. J Pediatr Surg. 47 (8): e21–3. doi:10.1016/j.jpedsurg.2012.03.090. PMID 22901938.
- ↑ D. S. Hartman & R. C. Sanders (1982). “Wilms’ tumor versus neuroblastoma: usefulness of ultrasound in differentiation”. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine. 1 (3): 117–122. PMID 6152936. Unknown parameter
|month=ignored (help) - ↑ J. F. De Campo (1986). “Ultrasound of Wilms’ tumor”. Pediatric radiology. 16 (1): 21–24. PMID 3003660.
- ↑ Sara E. Wobker & Sean R. Williamson (2017). “Modern Pathologic Diagnosis of Renal Oncocytoma”. Journal of kidney cancer and VHL. 4 (4): 1–12. doi:10.15586/jkcvhl.2017.96. PMID 29090117.
- ↑ Bita Geramizadeh, Mahmoud Ravanshad & Marjan Rahsaz (2008). “Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma”. Indian journal of pathology & microbiology. 51 (2): 167–171. PMID 18603673. Unknown parameter
|month=ignored (help) - ↑ Oleksandr N. Kryvenko, Merce Jorda, Pedram Argani & Jonathan I. Epstein (2014). “Diagnostic approach to eosinophilic renal neoplasms”. Archives of pathology & laboratory medicine. 138 (11): 1531–1541. doi:10.5858/arpa.2013-0653-RA. PMID 25357116. Unknown parameter
|month=ignored (help) - ↑ A. M. Amar, G. Tomlinson, D. M. Green, N. E. Breslow & P. A. de Alarcon (2001). “Clinical presentation of rhabdoid tumors of the kidney”. Journal of pediatric hematology/oncology. 23 (2): 105–108. PMID 11216700. Unknown parameter
|month=ignored (help) - ↑ T. I. Han, M. J. Kim, H. K. Yoon, J. Y. Chung & K. Choeh (2001). “Rhabdoid tumour of the kidney: imaging findings”. Pediatric radiology. 31 (4): 233–237. doi:10.1007/s002470000417. PMID 11321739. Unknown parameter
|month=ignored (help) - ↑ S. L. Gooskens, M. E. Houwing, G. M. Vujanic, J. S. Dome, T. Diertens, A. Coulomb-l’Hermine, J. Godzinski, K. Pritchard-Jones, N. Graf & M. M. van den Heuvel-Eibrink (2017). “Congenital mesoblastic nephroma 50 years after its recognition: A narrative review”. Pediatric blood & cancer. 64 (7). doi:10.1002/pbc.26437. PMID 28124468. Unknown parameter
|month=ignored (help) - ↑ Zuo-Peng Wang, Kai Li, Kui-Ran Dong, Xian-Min Xiao & Shan Zheng (2014). “Congenital mesoblastic nephroma: Clinical analysis of eight cases and a review of the literature”. Oncology letters. 8 (5): 2007–2011. doi:10.3892/ol.2014.2489. PMID 25295083. Unknown parameter
|month=ignored (help) - ↑ Hartman DS, Sanders RC (April 1982). “Wilms’ tumor versus neuroblastoma: usefulness of ultrasound in differentiation”. J Ultrasound Med. 1 (3): 117–22. PMID 6152936.
- ↑ De Campo JF (1986). “Ultrasound of Wilms’ tumor”. Pediatr Radiol. 16 (1): 21–4. PMID 3003660.
- ↑ Cahan LD (1985). “Failure of encephalo-duro-arterio-synangiosis procedure in moyamoya disease”. Pediatr Neurosci. 12 (1): 58–62. PMID 4080660.
- ↑ Jolly RD, Stellwagen E, Babul J, Vodkaĭlo LV, Titov VL, Moldomusaev DM, Maianskiĭ AN (November 1975). “Mannosidosis of Angus Cattle: a prototype control program for some genetic diseases”. Adv Vet Sci Comp Med. 19 (23): 1–21. PMID 1978.
- ↑ Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC (July 2015). “Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference”. Kidney Int. 88 (1): 17–27. doi:10.1038/ki.2015.59. PMC 4913350. PMID 25786098.
- ↑ Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D (January 2009). “Unified criteria for ultrasonographic diagnosis of ADPKD”. J. Am. Soc. Nephrol. 20 (1): 205–12. doi:10.1681/ASN.2008050507. PMC 2615723. PMID 18945943.
- ↑ Stavrou C, Koptides M, Tombazos C, Psara E, Patsias C, Zouvani I, Kyriacou K, Hildebrandt F, Christofides T, Pierides A, Deltas CC (October 2002). “Autosomal-dominant medullary cystic kidney disease type 1: clinical and molecular findings in six large Cypriot families”. Kidney Int. 62 (4): 1385–94. doi:10.1111/j.1523-1755.2002.kid581.x. PMID 12234310.
- ↑ Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A, Kimmel PL, Sperati CJ, Orr-Urtreger A, Ben-Shachar S, Waugh DA, McGinn S, Bleyer AJ, Hodanová K, Vylet’al P, Živná M, Hart TC, Hart PS (March 2014). “Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1”. Clin J Am Soc Nephrol. 9 (3): 527–35. doi:10.2215/CJN.06380613. PMC 3944763. PMID 24509297.
- ↑ Faguer S, Decramer S, Chassaing N, Bellanné-Chantelot C, Calvas P, Beaufils S, Bessenay L, Lengelé JP, Dahan K, Ronco P, Devuyst O, Chauveau D (October 2011). “Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood”. Kidney Int. 80 (7): 768–76. doi:10.1038/ki.2011.225. PMID 21775974.
- ↑ Heidet L, Decramer S, Pawtowski A, Morinière V, Bandin F, Knebelmann B, Lebre AS, Faguer S, Guigonis V, Antignac C, Salomon R (June 2010). “Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases”. Clin J Am Soc Nephrol. 5 (6): 1079–90. doi:10.2215/CJN.06810909. PMC 2879303. PMID 20378641.
- ↑ Bravo EL (1991). “Pheochromocytoma: new concepts and future trends”. Kidney Int. 40 (3): 544–56. PMID 1787652.
- ↑ Whalen RK, Althausen AF, Daniels GH (1992). “Extra-adrenal pheochromocytoma”. J Urol. 147 (1): 1–10. PMID 1729490.
- ↑ Baid SK, Lai EW, Wesley RA, Ling A, Timmers HJ, Adams KT; et al. (2009). “Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma”. Ann Intern Med. 150 (1): 27–32. PMC 3490128. PMID 19124817.
- ↑ Bravo EL (1991). “Pheochromocytoma: new concepts and future trends”. Kidney Int. 40 (3): 544–56. PMID 1787652.
- ↑ Burkitt lymphoma. MedlinePlus. https://www.nlm.nih.gov/medlineplus/ency/article/001308.htm Accessed on September 30, 2015
- ↑ Bellan C, Lazzi S, De Falco G, Nyongo A, Giordano A, Leoncini L (2003). “Burkitt’s lymphoma: new insights into molecular pathogenesis”. J. Clin. Pathol. 56 (3): 188–92. PMC 1769902. PMID 12610094. Unknown parameter
|month=ignored (help) - ↑ Ko HS, Schenk JP, Tröger J, Rohrschneider WK (2007). “Current radiological management of intussusception in children”. Eur Radiol. 17 (9): 2411–21. doi:10.1007/s00330-007-0589-y. PMID 17308922.
- ↑ Boyle MJ, Arkell LJ, Williams JT (1993). “Ultrasonic diagnosis of adult intussusception”. Am. J. Gastroenterol. 88 (4): 617–8. PMID 8470658.
- ↑ Neuroblastoma. Radiopaedia (2015) http://radiopaedia.org/articles/neuroblastoma Accessed on October, 8 2015
- ↑ Colon NC, Chung DH (2011). “Neuroblastoma”. Adv Pediatr. 58 (1): 297–311. doi:10.1016/j.yapd.2011.03.011. PMC 3668791. PMID 21736987.
- ↑ Neuroblastoma. Radiopaedia (2015) http://radiopaedia.org/articles/neuroblastoma Accessed on October, 8 2015
- ↑ Neuroblastoma. Libre Pathology(2015) http://librepathology.org/wiki/index.php/Adrenal_gland#Neuroblastoma Accessed on October, 5 2015
- ↑ Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Mesoblastic nephroma is a rare disease that tends to affect children under 3 years of age, especially neonates. [1][2] The male to female ratio is approximately 2 to 1.[3]
Epidemiology and Demographics
Prevalence
Mesoblastic nephroma accounts for approximately 3-6% of all renal neoplams in children.[1]
Age
Mesoblastic nephroma is a rare disease that tends to affect children under 3 years of age, especially neonates. [1][4]
Gender
Boys are more commonly affected with mesoblastic nephroma than girls. The male to female ratio is approximately 2 to 1.[3]
References
- ↑ 1.0 1.1 1.2 Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma
- ↑ Tavassoli, Fattaneh (2003). Pathology and genetics of tumours of the breast and female genital organs. Lyon: IAPS Press. ISBN 9283224124.
- ↑ 3.0 3.1 Furtwaengler R, Reinhard H, Leuschner I, Schenk JP, Goebel U, Claviez A; et al. (2006). “Mesoblastic nephroma–a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH)”. Cancer. 106 (10): 2275–83. doi:10.1002/cncr.21836. PMID 16596620.
- ↑ Tavassoli, Fattaneh (2003). Pathology and genetics of tumours of the breast and female genital organs. Lyon: IAPS Press. ISBN 9283224124.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
There are no established risk factors for mesoblastic nephroma.
Risk Factors
There are no established risk factors for mesoblastic nephroma.
References
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for mesoblastic nephroma.[1]
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for mesoblastic nephroma.[2]
References
- ↑ Mesoblastic nephroma. U.S. Preventive Service Task Force (USPSTF) 2015. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=mesoblastic+nephroma Accessed on November, 3, 2015
- ↑ Mesoblastic nephroma. U.S. Preventive Service Task Force (USPSTF) 2015. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=mesoblastic+nephroma Accessed on November, 3, 2015
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Complications of mesoblastic nephroma include stillbirth, shoulder dystocia at birth, hydrops fetalis, and respiratory distress syndrome. Prognosis is generally excellent, and the 5-year survival rate of patients with mesoblastic nephroma is approximately 96%.[1]
Complications
Potential complications of mesoblastic nephroma include:[2][3][4]
Prognosis
- Prognosis is generally excellent, and the 5-year survival rate of patients with mesoblastic nephroma is approximately 96%.[1]
References
- ↑ 1.0 1.1 van den Heuvel-Eibrink MM, Grundy P, Graf N, Pritchard-Jones K, Bergeron C, Patte C; et al. (2008). “Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups”. Pediatr Blood Cancer. 50 (6): 1130–4. doi:10.1002/pbc.21389. PMID 18095319.
- ↑ Mesoblastic nephroma.Dr Ayush Goel and Dr Yuranga Weerakkody et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/mesoblastic-nephroma
- ↑ Leclair MD, El-Ghoneimi A, Audry G, Ravasse P, Moscovici J, Heloury Y; et al. (2005). “The outcome of prenatally diagnosed renal tumors”. J Urol. 173 (1): 186–9. PMID 15592071.
- ↑ Liu YC, Mai YL, Chang CC, Chen KW, Chow SN (1996). “The presence of hydrops fetalis in a fetus with congenital mesoblastic nephroma”. Prenat Diagn. 16 (4): 363–5. doi:10.1002/(SICI)1097-0223(199604)16:4<363::AID-PD858>3.0.CO;2-O. PMID 8734816.
Diagnosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Biopsy
Treatment
Treatment
Medical therapy | Surgery | Primary prevention | Secondary prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Case Studies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
